MINNEAPOLIS, May 1, 2024
/PRNewswire/ -- Bio-Techne Corporation (NASDAQ: TECH)
announced that its Board of Directors has decided to pay a dividend
of $0.08 per share for the quarter
ended March 31, 2024. The quarterly
dividend will be payable May 24,
2024, to all common shareholders of record on May 13, 2024. Future cash dividends will be
considered by the Board of Directors on a quarterly basis.
Bio-Techne Corporation (NASDAQ: TECH) is a global life sciences
company providing innovative
tools and bioactive
reagents for the research
and clinical diagnostic communities. Bio-Techne
products assist scientific investigations into biological processes
and the nature and progress of specific diseases. They aid in drug
discovery efforts and provide the means for accurate clinical tests
and diagnoses. With thousands of products in its
portfolio, Bio-Techne generated approximately $1.1
billion in net sales in fiscal 2023 and
has approximately 3,200 employees worldwide. For more
information on Bio-Techne and its brands, please visit
www.bio-techne.com.
Forward Looking Statements:
Our press releases may contain forward-looking statements within
the meaning of the Private Securities Litigation Reform Act. Such
statements involve risks and uncertainties that may affect the
actual results of operations. Forward looking statements in this
press release include statements regarding potential future
repurchase of Bio-Techne common stock. The following important
factors, among others, have affected and, in the future, could
affect the Company's actual results and future share price: the
effect of new branding and marketing initiatives, the integration
of new businesses and leadership, the introduction and acceptance
of new products, the funding and focus of the types of research by
the Company's customers, the impact of the growing number of
producers of biotechnology research products and related price
competition, general economic conditions, customer site closures or
supply chain issues resulting from the COVID-19 pandemic, the
impact of currency exchange rate fluctuations, and the costs and
results of research and product development efforts of the Company
and of companies in which the Company has invested or with which it
has formed strategic relationships.
For additional information concerning such factors, see the
section titled "Risk Factors" in the Company's annual report on
Form 10-K and quarterly reports on Form 10-Q as filed with the
Securities and Exchange Commission. We undertake no obligation to
update or revise any forward-looking statements we make in our
press releases due to new information or future events. Investors
are cautioned not to place undue emphasis on these statements.
Contact:
|
David Clair, Vice
President, Investor Relations & Corporate Development
David.Clair@bio-techne.com
612-656-4416
|
View original content to download
multimedia:https://www.prnewswire.com/news-releases/bio-techne-declares-dividend-302132748.html
SOURCE Bio-Techne Corporation